drugset / Trial / NCT03183505

Comparison of Anyu Peibo With Placebo in Treatment of MDD,Ⅱb

NCT03183505 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of Anyu Peibo Capsule comparing with placebo in the treatment of Chinese Patients with Depression. And to provide some scientific evidence for protocol designing in following phase Ⅲ clinical trial.

Timeline

Start
2017-06-30
Primary completion
2018-10-05
Completion
2018-11-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Anyu Peibo Unknown 0.8 g Oral